Cytiva and the life sciences business of Pall Corp. have completed their integration as one business under the Cytiva brand. With nearly 16,000 associates in 40 countries, the new Cytiva supports customers in solving major biotechnology challenges to help advance and accelerate therapeutics.    In January 2023, the life sciences business of Pall separated from Pall Corp. Pall’s biotech portfolio is now a product family in Cytiva’s bioprocess business. The Pall medical portfolio will remain a m...